Ashraf Eassa
Long/short equity, contrarian, independent research, tech

A $234 Million Company Worth $0: Short Biozoom

Biozoom (OTC:BIZM) is a "development stage" company whose "plan of operation" does not involve generating any future revenue. The firm's only source of "net income" was from the "extinguishing of debt," and it is my belief that the current market capitalization of $234.14M is completely unwarranted in light of the fact that there is no underlying business, and I further believe that shares have simply been bid up due to a press release in which it touted the use of the "Biozoom scanner" was found - by Charite University Hospital Berlin - to lead to youth making "healthier choices" after using the scanner.

With the press release dubious and the underlying business non-existent, shares of Biozoom are likely...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details